Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.340
+0.037 (1.61%)
At close: Dec 5, 2025, 4:00 PM EST
2.320
-0.020 (-0.85%)
After-hours: Dec 5, 2025, 7:19 PM EST
Biomerica Employees
As of May 31, 2025, Biomerica had 54 total employees, including 53 full-time and 1 part-time employees. The number of employees decreased by 10 or -15.63% compared to the previous year.
Employees
54
Change (1Y)
-10
Growth (1Y)
-15.63%
Revenue / Employee
$90,444
Profits / Employee
-$67,685
Market Cap
6.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BMRA News
- 11 days ago - Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - GlobeNewsWire
- 4 weeks ago - Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand - GlobeNewsWire
- 7 weeks ago - Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S. - GlobeNewsWire
- 7 weeks ago - Biomerica Reports First Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 2 months ago - Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors - GlobeNewsWire
- 3 months ago - Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes - GlobeNewsWire
- 3 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use - GlobeNewsWire
- 3 months ago - Biomerica Reports Fiscal 2025 Year End Results - GlobeNewsWire